Literature DB >> 34271852

Engagement in perinatal depression treatment: a qualitative study of barriers across and within racial/ethnic groups.

Esti Iturralde1, Crystal A Hsiao2, Linda Nkemere2, Ai Kubo2, Stacy A Sterling2, Tracy Flanagan3, Lyndsay A Avalos2.   

Abstract

BACKGROUND: To better understand previously observed racial/ethnic disparities in perinatal depression treatment rates we examined care engagement factors across and within race/ethnicity.
METHODS: Obstetric patients and women's health clinician experts from a large healthcare system participated in this qualitative study. We conducted focus groups with 30 pregnant or postpartum women of Asian, Black, Latina, and White race/ethnicity with positive depression screens. Nine clinician experts in perinatal depression (obstetric, mental health, and primary care providers) were interviewed. A semi-structured format elicited treatment barriers, cultural factors, and helpful strategies. Discussion transcripts were coded using a general inductive approach with themes mapped to the Capability-Opportunity-Motivation-Behavior (COM-B) theoretical framework.
RESULTS: Treatment barriers included social stigma, difficulties recognizing one's own depression, low understanding of treatment options, and lack of time for treatment. Distinct factors emerged for non-White women including culturally specific messages discouraging treatment, low social support, trauma history, and difficulty taking time off from work for treatment. Clinician factors included knowledge and skill handling perinatal depression, cultural competencies, and language barriers. Participants recommended better integration of mental health treatment with obstetric care, greater treatment convenience (e.g., telemedicine), and programmatic attention to cultural factors and social determinants of health.
CONCLUSIONS: Women from diverse backgrounds with perinatal depression encounter individual-level, social, and clinician-related barriers to treatment engagement, necessitating care strategies that reduce stigma, offer convenience, and attend to cultural and economic factors. Our findings suggest the importance of intervention and policy approaches effecting change at multiple levels to increase perinatal depression treatment engagement.
© 2021. The Author(s).

Entities:  

Keywords:  Behavioral health integration; COM-B; Health equity; Perinatal depression; Racial disparities

Year:  2021        PMID: 34271852     DOI: 10.1186/s12884-021-03969-1

Source DB:  PubMed          Journal:  BMC Pregnancy Childbirth        ISSN: 1471-2393            Impact factor:   3.007


  4 in total

1.  Scaling Up Patient-Centered Psychological Treatments for Perinatal Depression in the Wake of a Global Pandemic.

Authors:  Daisy R Singla; Samantha Meltzer-Brody; Katarina Savel; Richard K Silver
Journal:  Front Psychiatry       Date:  2022-02-07       Impact factor: 4.157

2.  The Impact of COVID-19 on Postpartum Depression and the Responsibility of the Healthcare System.

Authors:  Sydney DiGregory; Nancy Githere; Kundai Crites; Caroline Rouse; Anthony Shanks
Journal:  Cureus       Date:  2022-08-09

3.  Gestational diabetes mellitus, prenatal maternal depression, and risk for postpartum depression: an Environmental influences on Child Health Outcomes (ECHO) Study.

Authors:  Lauren C Shuffrey; Maristella Lucchini; Santiago Morales; Ayesha Sania; Christine Hockett; Emily Barrett; Kecia N Carroll; Camille C Cioffi; Dana Dabelea; Sean Deoni; Anne L Dunlop; Arielle Deutsch; William P Fifer; Morgan R Firestein; Monique M Hedderson; Melanie Jacobson; Rachel S Kelly; Jean M Kerver; W Alex Mason; Hooman Mirzakhani; Thomas G O'Connor; Leonardo Trasande; Scott Weiss; Rosalind Wright; Yeyi Zhu; Rosa M Crum; Seonjoo Lee; Amy J Elliott; Catherine Monk
Journal:  BMC Pregnancy Childbirth       Date:  2022-10-08       Impact factor: 3.105

4.  Elevated Perinatal Depression during the COVID-19 Pandemic: A National Study among Jewish and Arab Women in Israel.

Authors:  Samira Alfayumi-Zeadna; Rena Bina; Drorit Levy; Rachel Merzbach; Atif Zeadna
Journal:  J Clin Med       Date:  2022-01-11       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.